C10AX13 evolocumab
ATC group of level 5 – chemical substance · in plain English: medicines lowering cholesterol, e.g. statins
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 no longer supplied or not available
Active substance: Evolocumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- C Cardiovascular system drugs 1,712 medicines
- C10 Lipid modifying agents 208 medicines
- C10A Lipid modifying agents, plain 191 medicines
- C10AX Other lipid modifying agents 23 medicines
- C10AX13 evolocumab 2 medicines
- C10AX Other lipid modifying agents 23 medicines
- C10A Lipid modifying agents, plain 191 medicines
- C10 Lipid modifying agents 208 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Repatha 140 mg solution for injection SPC no longer supplied | – |
| Repatha 420 mg solution for injection in cartridge SPC no longer supplied | – |
Other groups of the same level
- C10AX06 omega-3-triglycerides incl. other esters and acids 4 medicines
- C10AX09 ezetimibe 4 medicines
- C10AX10 alipogene tiparvovec 1 medicine
- C10AX12 lomitapide 3 medicines
- C10AX14 alirocumab 6 medicines
- C10AX15 bempedoic acid 1 medicine
- C10AX16 inclisiran 1 medicine
Other names of the ATC group
- Czech: C10AX13 Evolokumab
- German: C10AX13 Evolocumab
- Spanish: C10AX13 EVOLOCUMAB
- German: C10AX13 Evolocumab
- Italian: C10AX13 EVOLOCUMAB
- Turkish: C10AX13 evolocumab
- Portuguese (Brazil): C10AX13 Evolocumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group C10AX13
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.